Product Information
REBIF REBIDOSE 44 MCG/0.5 ML is a brand product labeled by EMD Serono, Inc., priced at $1848.6728 per ML under NDC 44087334401. Its NADAC has been published 97 times since Aug 21, 2024.
Strength
44 ug/.5mL
Manufacturer
EMD Serono, Inc.NDC
44087334401
Classification
Brand
Dosage Form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Last Updated
1/3/2026
Active Ingredients
INTERFERON BETA-1AApproval Type
Biologic (BLA)
FDA Application
BLA103780On Market Since
12/21/2012
Pharmacological Classes
Price Statistics
The NADAC for REBIF REBIDOSE 44 MCG/0.5 ML has been published 97 times since Aug 21, 2024, and over the history we have for it it has risen 8.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1848.6728 per ML |
|---|---|
| All-time high | $1848.6728 (Jun 24, 2026) |
| All-time low | $1700.1957 (Aug 21, 2024) |
| 52-week high | $1848.6728 |
| 52-week low | $1777.5700 |
| Median price | $1777.5700 |
| Average price | $1778.1490 |
| Largest weekly change | +4.0% (Feb 5, 2025) |
| Weeks tracked | 97 |
| Tracking since | Aug 21, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the INTERFERON BETA-1A market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of REBIF REBIDOSE 44 MCG/0.5 ML?
The current National Average Drug Acquisition Cost (NADAC) for REBIF REBIDOSE 44 MCG/0.5 ML, manufactured by EMD Serono, Inc., is $1848.6728 per ML (NDC 44087334401), effective Jun 24, 2026.
How has the price of REBIF REBIDOSE 44 MCG/0.5 ML changed over time?
Over the history we have for it, the NADAC for REBIF REBIDOSE 44 MCG/0.5 ML has risen 8.7%. It has been tracked across 97 weekly CMS publications since Aug 21, 2024.
What are the highest and lowest recorded NADAC prices for REBIF REBIDOSE 44 MCG/0.5 ML?
Since Aug 21, 2024, the NADAC for REBIF REBIDOSE 44 MCG/0.5 ML has ranged from a low of $1700.1957 (Aug 21, 2024) to a high of $1848.6728 (Jun 24, 2026), with a median of $1777.5700 per ML.
Are there cheaper alternatives to REBIF REBIDOSE 44 MCG/0.5 ML?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of REBIF REBIDOSE 44 MCG/0.5 ML, so no direct lower-cost alternative is listed.
Who manufactures REBIF REBIDOSE 44 MCG/0.5 ML?
REBIF REBIDOSE 44 MCG/0.5 ML (NDC 44087334401) is labeled by EMD Serono, Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification